Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Director Ernest Mario bought 100,000 shares of the business’s stock in a transaction that occurred on Tuesday, September 13th. The shares were bought at an average cost of $0.79 per share, for a total transaction of $79,000.00. Following the completion of the purchase, the director now owns 530,724 shares of the company’s stock, valued at $419,271.96. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) opened at 0.7149 on Tuesday. Tonix Pharmaceuticals Holding Corp. has a 1-year low of $0.70 and a 1-year high of $7.95. The firm has a 50 day moving average of $1.91 and a 200-day moving average of $2.25. The company’s market capitalization is $18.49 million.

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) last posted its quarterly earnings results on Monday, August 8th. The company reported ($0.50) EPS for the quarter, topping the consensus estimate of ($0.55) by $0.05. On average, equities research analysts anticipate that Tonix Pharmaceuticals Holding Corp. will post ($1.70) earnings per share for the current fiscal year.

Several research analysts recently issued reports on TNXP shares. Cantor Fitzgerald raised shares of Tonix Pharmaceuticals Holding Corp. from a “speculative buy” rating to a “buy” rating in a research note on Thursday, June 2nd. Oppenheimer Holdings Inc. lowered shares of Tonix Pharmaceuticals Holding Corp. from an “outperform” rating to a “market perform” rating in a research note on Wednesday, September 7th. Finally, Roth Capital lowered shares of Tonix Pharmaceuticals Holding Corp. from a “buy” rating to a “neutral” rating in a research note on Wednesday, September 7th.

Hedge funds and other institutional investors have recently bought and sold shares of the company. Franklin Resources Inc. increased its position in Tonix Pharmaceuticals Holding Corp. by 279.4% in the second quarter. Franklin Resources Inc. now owns 1,610,045 shares of the company’s stock valued at $3,204,000 after buying an additional 1,185,664 shares during the period. Opaleye Management Inc. acquired a new position in Tonix Pharmaceuticals Holding Corp. during the second quarter valued at approximately $1,592,000. Sabby Management LLC increased its position in Tonix Pharmaceuticals Holding Corp. by 52.0% in the second quarter. Sabby Management LLC now owns 585,914 shares of the company’s stock valued at $1,166,000 after buying an additional 200,518 shares during the period. Jacobs Levy Equity Management Inc. acquired a new position in Tonix Pharmaceuticals Holding Corp. during the first quarter valued at approximately $290,000. Finally, A.R.T. Advisors LLC acquired a new position in Tonix Pharmaceuticals Holding Corp. during the first quarter valued at approximately $117,000. 33.70% of the stock is currently owned by hedge funds and other institutional investors.

About Tonix Pharmaceuticals Holding Corp.

5 Day Chart for NASDAQ:TNXP

Receive News & Ratings for Tonix Pharmaceuticals Holding Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tonix Pharmaceuticals Holding Corp. and related companies with MarketBeat.com's FREE daily email newsletter.